PAHC
Phibro Animal Health Corp Health Care Pharmaceutical Preparations Russell 3000
$38.88Close
$28.31 – $59.1452-week range
Nov 4, 2026Next report · after the close
Highlights
Strengths
- Accumulation up-day volume 1.9× down-day volume over 50 sessions
- Earnings growing EPS +25% year on year, faster than the quarter before (+11 pts)
Cautions
- Not in an uptrend 2 of 8 trend conditions
- Lagging the market RS 34 · weaker than 66% of stocks over 12 months
- Far from its high 34% below its 52-week high
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
34%
1wk
up 0.2%
price change
1mo
up 8.8%
price change
12-month return
down 6%
market up 11% ·
its own down 15%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 17%
year on year
EPS growth
up 25%
latest quarter · +11 pts
Sales growth
up 5%
latest quarter · -6 pts
ROE
up 30%
return on equity
Free cash margin
up 1%
$9.9M FCF
D/E
1.91
long-term debt / equity
Net debt / EBITDA
2.8×
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- Gross margin 30.9% → 33.8%
Trade setup
ATR%
3.4%
$1.31 a day · 2×ATR $36.26
RS
34 / 99
vs the universe
Trend
2 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
1.92
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 2 of 8
- Price above the 50-day average: passes
- At least 30% above the 52-week low: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Profit not backed by cash Reported profit of $99.7M came with $69.0M of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
Last reported
Aug 26, 2026
Results reaction
Aug 26, 20260% vs market2 sessions after results
Financials
- Gross 34%
- Net 7%
- Free cash 1%
- Cash
- Long-term debt
| FY2021Jun 30, 2021 | FY2022Jun 30, 2022 | FY2023Jun 30, 2023 | FY2024Jun 30, 2024 | FY2025Jun 30, 2025 | FY2026Jun 30, 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $833.4M | $942.3M | $977.9M | $1.0B | $1.3B | $1.5B |
| Gross margin | 33% | 30% | 30% | 31% | 31% | 34% |
| Operating income | $74.9M | $79.0M | $71.8M | $53.3M | $110.5M | $194.4M |
| Net income | $54.4M | $49.2M | $32.6M | $2.4M | $48.3M | $99.7M |
| Net margin | 7% | 5% | 3% | 0% | 4% | 7% |
| Earnings per share | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | $2.43 |
| Free cash flow | $19.0M | -$5.4M | -$38.5M | $46.4M | $41.8M | $9.9M |
| Free cash margin | 2% | -1% | -4% | 5% | 3% | 1% |
| Cash | $50.2M | $74.2M | $41.3M | $70.6M | $68.0M | $61.4M |
| Long-term debt | $298.1M | $272.9M | $311.5M | $282.3M | $615.4M | $737.9M |
| Shareholders' equity | $238.5M | $262.4M | $282.5M | $256.6M | $285.7M | $385.5M |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 26, 2026 | Annual ↗ | Jun 30, 2026 | 57d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Feb 4, 2026 | Quarterly ↗ | Dec 31, 2025 | 35d |
| Nov 5, 2025 | Quarterly ↗ | Sep 30, 2025 | 36d |
| Aug 27, 2025 | Annual ↗ | Jun 30, 2025 | 58d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 5, 2025 | Quarterly ↗ | Dec 31, 2024 | 36d |
| Nov 6, 2024 | Quarterly ↗ | Sep 30, 2024 | 37d |
| Aug 28, 2024 | Annual ↗ | Jun 30, 2024 | 59d |
| May 8, 2024 | Quarterly ↗ | Mar 31, 2024 | 38d |
| Feb 7, 2024 | Quarterly ↗ | Dec 31, 2023 | 38d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 26, 2026 | Results ↗ |
| Jul 28, 2026 | Other events ↗ |
| Jun 26, 2026 | Director or officer change ↗ |
| May 6, 2026 | Results ↗ |
| May 5, 2026 | Other events ↗ |
| Apr 30, 2026 | Material agreement · New obligation ↗ |
| Apr 27, 2026 | Regulation FD ↗ |
| Apr 14, 2026 | Director or officer change ↗ |
| Feb 4, 2026 | Results ↗ |
| Feb 3, 2026 | Other events ↗ |
| Dec 18, 2025 | Director or officer change · Regulation FD ↗ |
| Nov 5, 2025 | Results · Shareholder vote ↗ |